6177-60-2

Usage

Main properties

1. Chemical compound used as a crosslinking agent
2. Clear, colorless liquid with a faint odor
3. Used in production of polymers, adhesives, sealants, resins, surface coatings, paper products, textiles, and leather

Specific content

1. Also known as glycidyl mesylate
2. Used as a stabilizer in resin manufacture
3. Acts as a dye fixative and tanning agent in textiles and leather industries
4. Considered a potential irritant to skin, eyes, and respiratory system
5. May have harmful effects on aquatic organisms

InChI:InChI=1/C4H8O4S/c1-9(5,6)8-3-4-2-7-4/h4H,2-3H2,1H3

Upstream product

• 556-52-5 oxiranyl-methanol 
• 7143-01-3 Methanesulfonic anhydride 

Downstream Products

• 75-75-2 methanesulfonic acid 
• 6387-87-7 2-Hydroxy-3-chlor-propyl-methan-sulfonat 

Relevant academic research and scientific papers

Oxiranyl ester derivatives as additive for electrolytes in lithium ion batteries

The present invention relates to an electrolyte composition (A) containing (i) at least one aprotic organic solvent; (ii) at least one conducting salt; (iii) at least one compound of formula (I) and (iv) optionally at least one further additive.

ARYLAMINOALCOHOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINOLINES

The present invention relates to substituted phenoxypyridine compounds of general foumula (I); in which R1, R2 and R3 are as defined in the claims, to methods of preparing said compounds, to intermediates for the preparation of said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and /or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

ALKOXY-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES

The present invention relates to alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazoline compounds of general formula (I) in which R1, R2 and R3 are as defined in the claims, to methods of preparing said compounds, to intermediates for the preparation of said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.